Cargando…
Synthesis of PP2A-Activating PF-543 Derivatives and Investigation of Their Inhibitory Effects on Pancreatic Cancer Cells
Sphingosine kinase (SK) is involved in the growth of cells, including cancer cells. However, which of its two isotypes—SK1 and SK2—is more favorable for cancer growth remains unclear. Although PF-543 strongly and selectively inhibits SK1, its anticancer effect is not high, and the underlying reason...
Autores principales: | Kim, Su Bin, Oh, Yoon Sin, Kim, Kwang Joon, Cho, Sung Woo, Park, Seung Ki, Baek, Dong Jae, Park, Eun-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145885/ https://www.ncbi.nlm.nih.gov/pubmed/35630821 http://dx.doi.org/10.3390/molecules27103346 |
Ejemplares similares
-
Synthesis and Biological Evaluation of BODIPY-PF-543
por: Shrestha, Jitendra, et al.
Publicado: (2019) -
Verification of the Necessity of the Tolyl Group of PF-543 for Sphingosine Kinase 1 Inhibitory Activity
por: Kim, Su Bin, et al.
Publicado: (2020) -
Novel Dimer Derivatives of PF-543 as Potential Antitumor Agents for the Treatment of Non-Small Cell Lung Cancer
por: Kim, Su Bin, et al.
Publicado: (2022) -
Induction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells
por: Hamada, Masakazu, et al.
Publicado: (2017) -
MicroRNA-543 controls pancreatic cancer development by LINC00847-microRNA-543-STK31 axis
por: Liu, Yan, et al.
Publicado: (2022)